Alimera Sciences, Inc. (ALIM) financial statements (2021 and earlier)

Company profile

Business Address 6120 WINDWARD PARKWAY
ALPHARETTA, GA 30005
State of Incorp.
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1191324313177
Cash and cash equivalents1191324313177
Restricted cash and investments000000 
Receivables1719171114101
Inventory, net of allowances, customer advances and progress billings3122022
Inventory3122022
Deferred costs      1
Other undisclosed current assets4322233
Total current assets:35333539474583
Noncurrent Assets
Finance lease, right-of-use asset 0
Operating lease, right-of-use asset11
Property, plant and equipment2 11232
Intangible assets, net (including goodwill)13151719212324
Intangible assets, net (excluding goodwill)13151719212324
Deferred income tax assets11
Deferred tax assets, net   00
Other undisclosed noncurrent assets 1110 (0)
Total noncurrent assets:16181921232526
TOTAL ASSETS:515054607070109
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1112109986
Accounts payable7766545
Accrued liabilities3544441
Interest and dividends payable      0
Debt20000321
Derivative instruments and hedges, liabilities    0 16
Deferred tax liabilities    0
Other undisclosed current liabilities     0(13)
Total current liabilities:1212101094010
Noncurrent Liabilities
Long-term debt and lease obligation43003533133
Long-term debt, excluding current maturities42  3433 33
Finance lease, liability10
Capital lease obligations00010
Liabilities, other than long-term debt4431210
Other liabilities4431210
Total noncurrent liabilities:46433536133
Total liabilities:59161445454144
Stockholders' equity
Stockholders' equity attributable to parent, including:(8)(4)315262650
Common stock001  00
Additional paid in capital366350346342331299293
Accumulated other comprehensive loss(1)(1)(1)(1)(1)(1)(1)
Accumulated deficit(393)(388)(377)(399)(377)(344)(313)
Warrants and rights outstanding044    
Other undisclosed stockholders' equity attributable to parent19303073737270
Total stockholders' equity:(8)(4)315262650
Other undisclosed liabilities and equity 3938  316
TOTAL LIABILITIES AND EQUITY:515054607070109

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues5154473634228
Cost of revenue
(Cost of Goods and Services Sold)
(7)(7) (3)(2)(2)(1)
Other undisclosed gross profit  (5)    
Gross profit:4447423232217
Operating expenses(44)(53)(52)(49)(60)(60)(40)
Operating loss:(1)(5)(10)(16)(28)(39)(33)
Nonoperating income (expense)
(Foreign Currency Transaction Gain (Loss), before Tax)
0(0)(0)0(0)(0)(1)
Interest and debt expense(5)(5)(7)(6)(8)(5)(3)
Other undisclosed income from continuing operations before equity method investments, income taxes   03130
Loss from continuing operations before equity method investments, income taxes:(5)(10)(16)(22)(33)(31)(36)
Other undisclosed loss from continuing operations before income taxes      (0)
Loss from continuing operations before income taxes:(5)(10)(16)(22)(33)(31)(36)
Income tax expense (benefit)0(0)(0)(0)(0)(0)(0)
Net loss attributable to parent:(5)(10)(16)(22)(33)(31)(36)
Preferred stock dividends and other adjustments  38    
Undistributed earnings (loss) allocated to participating securities, basic  4 
Other undisclosed net loss available to common stockholders, basic  (4)   (1)
Net income (loss) available to common stockholders, diluted:(5)(10)22(22)(33)(31)(37)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net loss:(5)(10)(16)(22)(33)(31)(36)
Other comprehensive income (loss) (0)(0)0(0)(0)(0)
Comprehensive loss:(5)(11)(17)(22)(33)(31)(36)
Other undisclosed comprehensive income, net of tax, attributable to parent1      
Comprehensive loss, net of tax, attributable to parent:(5)(11)(17)(22)(33)(31)(36)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: